Third generation oral contraceptives

BMJ 1996; 312 doi: http://dx.doi.org/10.1136/bmj.312.7030.576 (Published 2 March 1996)
Cite this as: BMJ 1996;312:576.1

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

CSM's advice will harm women's health worldwide

  1. Evert Ketting
  1. Deputy director Netherlands Institute of Social Sexological Research, Utrecht, Netherlands

    EDITOR,—The Committee on Safety of Medicines' recent advice that oral contraceptives containing gestodene or desogestrel should not be prescribed1 has caused confusion and concern among family planning specialists and has major public health implications.

    In 1977 the Royal College of General Practitioners concluded that women aged over 35 and heavy smokers aged over 30 should not use oral contraceptives because of an increased risk of cardiovascular disease.2 These conclusions were highlighted in the Dutch media and caused a drop in the use of oral contraceptives from 34% to 27%, …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL